Neurocrine Biosciences, Inc. (BIT:1NBIX)
Italy
· Delayed Price · Currency is EUR 107.70
+2.60 (2.47%)
At close: May 12, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Total Collaboration | 27.30M |
Log In |
Log In |
Log In |
Log In |
| Total Collaboration Growth | -1.44% |
Log In |
Log In |
Log In |
Log In |
| INGREZZA | 2.35B |
Log In |
Log In |
Log In |
Log In |
| INGREZZA Growth | 21.80% |
Log In |
Log In |
Log In |
Log In |
| Total Net Product | 2.39B |
Log In |
Log In |
Log In |
Log In |
| Total Net Product Growth | 22.05% |
Log In |
Log In |
Log In |
Log In |
| Royalties | 22.70M |
Log In |
Log In |
Log In |
Log In |
| Royalties Growth | 7.58% |
Log In |
Log In |
Log In |
Log In |
| Milestones | - |
Log In |
Log In |
Log In |
Log In |
| Milestones Growth | - |
Log In |
Log In |
Log In |
Log In |
| Collaboration and Other | 4.60M |
Log In |
Log In |
Log In |
Log In |
| Collaboration and Other Growth | -30.30% |
Log In |
Log In |
Log In |
Log In |
| ONGENTYS and Other Product | 18.10M |
Log In |
Log In |
Log In |
Log In |
| ONGENTYS and Other Product Growth | -20.26% |
Log In |
Log In |
Log In |
Log In |